GSK, But Not Execs, May Be Relieved From Prosecution In China: Sources
This article was originally published in PharmAsia News
Executive Summary
Sources from the legal and pharma sectors said that GlaxoSmithKline China’s compliance investigation may result in Chinese authorities charging many of its China executives, but not the company.